Satyendra Dhar, MD SFHM (@dharsaty) 's Twitter Profile
Satyendra Dhar, MD SFHM

@dharsaty

Assist Clin Professor, 🗣️ The more I read, the more I acquire, the more certain I am that I know Nothing🫀
Support: Dharsaty.com/p/scholarship.…

ID: 1262408459636674560

linkhttps://www.DharSaty.com calendar_today18-05-2020 15:44:31

1,1K Tweet

9,9K Followers

338 Following

Satyendra Dhar, MD SFHM (@dharsaty) 's Twitter Profile Photo
Satyendra Dhar, MD SFHM
@dharsaty

3 months ago

Patients with HF and ESRD on HD have been excluded from landmark trials of all these therapies. GDMT in patients with HFrEF who are on dialysis is often withheld or not uptitrated to recommended target doses due to safety and tolerability concerns and lack of available clinical

Patients with HF and ESRD on HD have been excluded from landmark trials of all these therapies. GDMT in patients with HFrEF who are on dialysis is often withheld or not uptitrated to recommended target doses due to safety and tolerability concerns and lack of available clinical